Plus   Neg

Stock Alert: OptiNose Up 17%

Shares of OptiNose, Inc. (OPTN) jumped over 17% on Tuesday morning after pharmaceutical company announced an anti-COVID-19 product candidate.

OPTN is currently trading at $7.56, up $1.14 or 17.76%, on the Nasdaq.

Optinose initiated the development of a new product candidate, OPN-019, which combined with the company's nasal Exhalation Delivery System (EDS) technology with an antiseptic is expected to kill the virus that causes COVID-19.

The company said it expects to be able to rapidly progress to a meeting with FDA to discuss an IND and then onward to clinical trials, as components of the drug-device combination product candidate, including both the active drug and delivery device, are currently commercially available in the U.S.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) Wednesday reported a first-quarter profit that trumped Wall Street estimates, as the iPhone maker's revenues topped $100 billion driven by strong demand for latest iPhones and wearables segment. Apple's first-quarter profit rose to $28.76 billion or $1.68 per share from $22.24 billion... Shares of Tesla Motors Inc. (TSLA) slipped 5% in extended trading session on Wednesday after the luxury electric car maker reported a profit for the fourth quarter that fell short of Wall Street analysts' estimates. Palo Alto, California-based Tesla reported fourth-quarter profit of $270 million or... Walmart said it plans to scale the number of stores that will also serve as local fulfillment centers, noting that its customers love the speed and convenience of pickup and delivery. According to the retail giant, dozens of stores will become local fulfilment centers, with many more to come later. A portion of these stores will be converted into automated warehouses.
Follow RTT